A former Vanderbilt University biomedical engineer committed fraud on a massive scale, according to a new Office of Research Integrity (ORI) report.
Igor Dzhura is banned from receiving federal funding for three years, and is retracting six papers, which have been cited more than 500 times. Since leaving Vanderbilt, he has worked at SUNY Upstate Medical University, and now works at Novartis.
According to the ORI, Dzhura was a busy boy at Vanderbilt, faking images and drastically inflating the number of experiments he conducted by duplicating computer files and saving them in nested folders. The total body count from his work includes: Continue reading Updated: Former Vanderbilt scientist faked nearly 70 images, will retract 6 papers: ORI
One of the complaints we often hear about the self-correcting nature of science is that authors and editors seem very reluctant to retract papers with obvious fatal flaws. Indeed, it seems fairly clear that the number of papers retracted is smaller than the number of those that should be.
To try to get a sense of how errors are corrected in the literature, Arturo Casadevall, Grant Steen, and Ferric Fang, whose work on retractions will be familiar to our readers, in a new paper in the FASEB Journal, look at the sources of error in papers retracted for reasons other than misconduct.
Here’s the abstract (emphasis ours): Continue reading “Barriers to retraction may impede correction of the literature:” New study
We have an update on the complicated story of Milena Penkowa and Bente Klarlund Pedersen.
Two papers coauthored by the pair — who have both been found guilty of scientific dishonesty by the Danish Committees on Scientific Dishonesty — have been retracted by the FASEB Journal.
Here’s one notice (both are unfortunately behind a paywall): Continue reading Penkowa-Pedersen paper retracted nearly three years after being subjected to Notice of Concern
Two years ago, the FASEB Journal retracted a paper that it had initially agreed to correct, after a dean at one of the author’s institutions said that a “well-recognized and top-class fact ﬁnding commission concluded that the publication contains gross ﬂaws.” The retraction of the 2003 paper, as we noted at the time, punctuated a complicated case involving several investigations as well as legal maneuvering.
Now, the journal has retracted the retraction. Here’s the beginning of the notice: Continue reading Bitter legal fight leads to a retracted retraction
The FASEB Journal has retracted a 2012 paper by a group from the University of Alabama, Birmingham (UAB), looking at the role of a tumor-suppressing micro-RNA in pulmonary fibrosis. The retraction suggests the provenance of the data are in question, and we learned details of what went wrong.
Here’s the notice, which, sadly, is behind a $12-per-day paywall: Continue reading Author retracts FASEB Journal paper for data reuse
The FASEB Journal — FASEB stands for the Federation of American Societies for Experimental Biology — is retracting a 15-year-old paper without the consent of all of the authors, despite what seem like valiant attempts to figure out exactly what went wrong.
Here’s the notice for the University of Bern-University of Urbino paper:
Continue reading FASEB J retracts 15-year-old study after author comes forward, but universities decline to investigate
A contested retraction has punctuated the complicated saga of a 2003 paper in the FASEB Journal. (FASEB stands for the Federation of American Societies for Experimental Biology.)
A retraction notice for the paper, “Molecular analysis of Nogo expression in the hippocampus during development and following lesion and seizure,” appeared in mid-June: Continue reading Following investigation, FASEB Journal retracts paper after agreeing to run a correction
There’s another retraction in the the complicated case of Milena Penkowa, the former University of Copenhagen researcher being investigated for scientific misconduct and misuse of grant funds. The paper, in Experimental Physiology, was titled “Exercise-induced metallothionein expression in human skeletal muscle fibres” and was published online in January 2005.
It’s the second retraction for Penkowa, who did not sign either of them. According to the notice: Continue reading Another retraction for Milena Penkowa, this one in Experimental Physiology
As we reported earlier this week, two journals have issued Expressions of Concern about papers by Milena Penkowa, who is under investigation for scientific misconduct and misuse of grants. Now we learn that the FASEB Journal has published a Notice of Concern about a third paper: Continue reading A third Milena Penkowa paper, in FASEB Journal, now subject to Notice of Concern
The number of retraction notices of papers co-authored by Silvia Bulfone-Paus is up to eight.
The Journal of Leukocyte Biology, which was apparently the first to announce they had accepted a retraction, has published its notice: Continue reading Two more Bulfone-Paus retraction notices appear